Neurostimulation is being studied as a possible approach for ADHD, and the research so far is mixed. A 2019 review found “mixed results” and called for more research with larger sample sizes. Neither the 2019 review nor the NIH project record names an ADHD neurostimulation device or an FDA record, so matching a specific device to its FDA record is a step you take with the exact model you are considering.
Can neurostimulation be used to treat ADHD?
The 2019 review in Psychiatria Danubina concludes that “Neurostimulation techniques have potential in treating ADHD, with some studies having positive results.” It also reports that “Mixed results have been found in the effectiveness of neurostimulatory methods in treating ADHD.” The review describes these techniques as “stimulation of brain areas showing abnormal activity in ADHD” and as “associated with benefits that last longer with fewer side effects.” Those are the review’s own background statements.
The review searched PubMed and the Cochrane Library for transcranial magnetic stimulation, transcranial direct current stimulation, vagus nerve stimulation, trigeminal nerve stimulation, deep brain stimulation, electroconvulsive therapy and ultrasound stimulation combined with ADHD. It found 417 references and used 30 of them. For readers who want to compare with other non-drug options, the parent training for adhd guide covers a different approach, and the neurofeedback for adhd page covers another technique with its own evidence questions.
Which device and FDA record apply?
Neither the 2019 review nor the NIH project record names an ADHD neurostimulation device or an FDA record. The answer depends on the exact model you are considering. Search the FDA’s own device records by model name, then use the checklist below to compare that record with the claim on the seller’s page.
| What to check | Where to look | Why it helps |
|---|---|---|
| Exact product name and model number | The device label and the seller’s listing | A similar name may be a different model. |
| FDA record for that model | FDA’s device records, searched by model name | It lets you check the model against its own record. |
| Intended use written in the record | The FDA record itself | Compare it word for word with the ADHD claim. |
| Software or firmware version | The package, the app store listing or the manual | It shows which version you are checking. |
| Each claim on the seller’s page | The product page | Set each claim beside the intended use in the record. |
What clinical evidence is still missing?
An NIH-funded project record on RePORTER describes a planned randomized trial of external trigeminal nerve stimulation for ADHD in children aged 7 to 12, with a planned sample of 180 and UCLA listed as the awardee organization. Its stated goal is to test efficacy. The record says that “Confirming the efficacy of TNS for ADHD could provide millions of families a viable non-pharmacological treatment option,” which describes the goal of the study, not a result.
The project end date is January 31, 2027. The same record notes that psychostimulants are “the gold standard of treatment for ADHD,” and that a reliable way to predict who will respond to treatment “remains elusive.” Both points explain why researchers are looking at non-drug options. Neither is a result for any device.
What about safety?
The review’s background says the techniques are associated with fewer side effects. The trial record describes its method as “a novel, minimal risk, non-invasive neuromodulation treatment.” Those are the authors’ descriptions. They are not a safety test result for ADHD use.
For safety, ask the maker for the side effects reported in its own studies, the ages of the people tested, and who was excluded from testing. Ask for these in writing before you order.
Does an app’s performance show real-world benefit for ADHD?
There is no data here on how any ADHD device app performs. The closest guidance comes from the National Institute on Aging, which says: “Beware of claims that playing certain computer and online games can improve your memory and thinking. There currently is not enough evidence available to suggest that commercially available computer-based brain-training applications have the same impact on cognitive abilities as the ACTIVE study training.”
That passage is about older adults and computer and online games or brain-training apps for memory and thinking. It does not evaluate any ADHD device app. Treat an in-app score as the device’s own feedback, and ask the maker what that score measured and whether its studies tracked everyday outcomes.
How do you judge the wording of an ADHD claim?
As of October 5, 2026, the Federal Trade Commission’s health products compliance guidance says that claims about the health benefits or safety of health-related products “require substantiation in the form of competent and reliable scientific evidence.” It also says that “it’s not enough to say that the product ‘may’ have the claimed benefit or ‘helps’ achieve the claimed benefit.” When you read a device page, check whether it names the condition and whether the wording is firmer than “may” or “helps.” This is general information, not legal advice.
Before you order
- Match the exact model to its FDA record and read the intended use in that record.
- Ask the seller for the record number, the software version and the side-effect data from its own studies.
- Check the ADHD claim against the intended use word for word.
- Ask what any app score measured and whether the maker has outcome data from its own studies.
Which specific device works for ADHD, whether any benefit lasts beyond a study, and how a device performs for your child or for you are still open questions. Start with the FDA record for the exact model, and compare it with the claim before you spend money.
By the Global MH Summit Research Team
This article is for general information purposes only and does not constitute medical advice. Consult your doctor or qualified healthcare provider before making changes to your health routine.